Last reviewed · How we verify
Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Tobi · Novartis
- Vantobra · Pfizer
- Nebcin · University Hospital, Lille
- Noroxin
- Floxin
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa patent landscape — cliff calendar, originator estates, attackable patents
- Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa treatment landscape brief
- Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa treatment updates RSS
Frequently asked questions about Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa
What drugs treat Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa?
Tracked treatments include Ramycin, Tobi, Vantobra, Nebcin, Noroxin, Floxin, Levaquin, Ofloxacine.
What is the treatment for Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa?
Standard treatment for Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa includes Ramycin, Tobi, Vantobra, Nebcin, Noroxin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa patent cliff · Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa CI report
- Treatment: Ramycin
- Treatment: Tobi · Novartis
- Treatment: Vantobra · Pfizer
- Treatment: Nebcin · University Hospital, Lille
- Treatment: Noroxin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing